Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...

After months of waiting, a young boy from Cuba battling a medical condition is getting a second chance at life after he and his family received a visa to travel to South Florida for treatment. Damir ...

Shares of SpringWorks Therapeutics SWTX have rallied 32.9% in the past three months compared with the industry’s increase of ...

Researchers have found in a nonrandomised pilot trial that selumetinib showed a reduction in cutaneous neurofibromatosis ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

Rising Demand for Water Treatment Solutions Governments and industries worldwide are increasingly focusing on sustainable ...

Discover a study that used the Skindex-29 assessment to evaluate emotional wellbeing during selumetinib cycles.

Genetic changes alone don’t fully explain tumor growth in NF-1, pointing to other contributing factors. This insight may ...

Specialty chemicals company LANXESS will be presenting its innovative products and developments for a more efficient and ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA ...

Ovarian cancer (OC), the most lethal gynecological malignancy, is the fifth leading cause of cancer-related death in women. Despite advances in treatment, the primary challenges in overcoming ovarian ...